Functional Characterization of CXCL14, CXCL17, and CCL28; three mucosal chemokine
Functional Characterization of CXCL14, CXCL17, and CCL28; three mucosal chemokine
批准号:
7888274
负责人:
Albert Zlotnik
金额:
$18.93万
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-07-15 至 2011-12-30
关键词:
AddressBiological MarkersBody cavitiesBronchiCXCL14 geneCandidaCandida albicansCandidiasisCellsChlamydiaChlamydia trachomatisDataDefensinsDevelopmentDiseaseDuodenumEnvironmentEpitheliumEquilibriumEsophagusExhibitsFemaleFlavoringFutureGenesHomeostasisHumanHuman bodyImmuneImmunohistochemistryIn Situ HybridizationInfectionInflammatoryInflammatory ResponseKnockout MiceLeukocytesLigandsLinkLocationMapsMeasuresMediatingMicrobeMolecularMorphologyMucosal ImmunityMucous MembraneMusOral cavityOrganOrganismPathway interactionsPeriodontal DiseasesPhysiological ProcessesPlayPopulationPropertyProteinsReportingRoleSalivaSalivary GlandsSiteSodium ChlorideSterilityStomachSurveysTaste Bud CellTaste BudsTaste PerceptionTestingTissuesTongueTracheaTranscriptUrethraVaginaantimicrobialbody cavitychemokinegastrointestinal systemmembermicrobialmicrobicidemicroorganismmucosal sitereproductiveresearch study
中文摘要
描述(由申请人提供):粘膜免疫包括许多分子实体,其中许多仍然知之甚少。我们使用基因阵列分析鉴定了三种趋化因子(CXCL14, CXCL17和CCL28),它们在人粘膜组织中表现出非常高的表达。只有这三种趋化因子(在48种已知的人类配体中)与粘膜组织表现出这种密切的联系。这些趋化因子可能代表了一些最丰富的蛋白质,例如,在人类唾液中,但我们对它们知之甚少。此外,它们在粘膜免疫中的作用几乎未被探索。因此,我们的目标是研究这些“粘膜”趋化因子。在具体目标1中,我们将通过免疫组织化学和/或原位杂交绘制各种粘膜组织(口腔、支气管、气管、食道、肠道和女性生殖道)中产生这些趋化因子的细胞。这些结果将为未来的实验指明方向,旨在更详细地评估这些趋化因子在粘膜免疫中的作用。在具体目标2中,我们将测试这些趋化因子具有杀微生物活性的假设。我们将测试几种微生物,包括革兰氏(+)、革兰氏(-)、白色念珠菌和沙眼衣原体。如果得到证实,这一结果将表明这些趋化因子可能是维持人体腔粘膜与这些部位的正常或致病菌群之间平衡的主要参与者。例如,这些趋化因子可能在牙周病或阴道念珠菌病等疾病中发挥重要作用。最后,我们观察到其中一种趋化因子CXCL14在味蕾中特异性表达,而在舌上皮中不表达。我们将使用味蕾细胞的各种生物标志物(那些介导甜、苦、鲜味和酸味觉感知的细胞以及前体味觉细胞)分析CXCL14基因敲除小鼠的味蕾。这些实验将表明CXCL14-/-小鼠的味蕾是否表现出任何改变,并可能指出CXCL14在味蕾发育中的作用。综上所述,这些实验将为我们提供对这些趋化因子在粘膜组织中的功能的新认识。本项目旨在表征三种高表达于粘膜组织的趋化因子(CXCL14、CXCL17、CCL28),包括人体各腔(口腔、阴道等)的粘膜组织。它将探讨这些趋化因子的几种潜在功能,包括杀微生物活性以及CXCL14在味蕾发育中的潜在作用。
英文摘要
DESCRIPTION (provided by applicant): Mucosal Immunity includes many molecular entities, many of which remain poorly understood. We have used gene array analyses to identify three chemokines (CXCL14, CXCL17 and CCL28) that exhibit very high expression in human mucosal tissues. Only these three chemokines (out of 48 known human ligands) exhibit this close association with mucosal tissues. These chemokines likely represent some of the most abundant proteins present, for example, in human saliva, yet we know very little about them. Furthermore, their role in mucosal immunity is virtually unexplored. We therefore aim to study these 'mucosal' chemokines. In Specific aim 1, we will map the cells that produce these chemokines in the various mucosal tissues (oral cavity, bronchus, trachea, esophagus, gut and the female reproductive tract) by immunohistochemistry and/or in situ hybridization. These results will point to future experiments aimed at evaluating in greater detail the role of these chemokines in mucosal immunity. In Specific aim 2, we will test the hypothesis that these chemokines have microbicidal activity. We will test several microorganisms, including gram (+), gram (-), Candida albicans and Chlamydia trachomatis. If confirmed, this result would indicate that these chemokines may be major players in maintaining the balance between the mucosa of human body cavities and normal or pathogenic flora present in these sites. For example, these chemokines may play major roles in diseases such as periodontal disease, or vaginal candidiasis. Finally, we have observed that one of these chemokines, CXCL14, is specifically expressed in taste buds but not in lingual epithelium. We will analyze the taste buds of CXCL14 knockout mice using various biomarkers of taste bud cells (those that mediate sweet, bitter, umami and sour taste perception as well as precursor taste cells). These experiments will indicate whether the taste buds of CXCL14-/- mice exhibit any alterations and may point to a role for CXCL14 in taste bud development. Taken together, these experiments should provide us with a new understanding of the functions of these chemokines in mucosal tissues. This project aims to characterize three chemokines (CXCL14, CXCL17, CCL28) that are highly expressed in mucosal tissues including those in various human body cavities (oral cavity, vagina, etc). It will explore several potential functions of these chemokines including microbicidal activity as well as a potential role of CXCL14 in taste bud development.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1016/j.immuni.2012.05.008
发表时间:
2012-05-25
期刊:
Immunity
影响因子:
32.4
作者:
[Zlotnik A, Yoshie O]
通讯作者:
Yoshie O
Role of meteorin-like in the immune system
-
批准号:9227004
-
项目类别:
-
资助金额:$22.28万
-
财政年份:2016
-
负责人:Albert Zlotnik
-
依托单位:
Role of meteorin-like in the immune system
-
批准号:9398097
-
项目类别:
-
资助金额:$18.41万
-
财政年份:2016
-
负责人:Albert Zlotnik
-
依托单位:
Functional characterization of IL-40, a novel cytokine
-
批准号:8872593
-
项目类别:
-
资助金额:$23.18万
-
财政年份:2015
-
负责人:Albert Zlotnik
-
依托单位:
Characterization of CCL28,CXCL14, and CXCL17, three mucosal chemokines
-
批准号:8392254
-
项目类别:
-
资助金额:$35.35万
-
财政年份:2011
-
负责人:Albert Zlotnik
-
依托单位:
Characterization of IL36, a novel cytokine
-
批准号:8264156
-
项目类别:
-
资助金额:$18.31万
-
财政年份:2011
-
负责人:Albert Zlotnik
-
依托单位:
Characterization of CCL28,CXCL14, and CXCL17, three mucosal chemokines
-
批准号:8235704
-
项目类别:
-
资助金额:$37.59万
-
财政年份:2011
-
负责人:Albert Zlotnik
-
依托单位:
Characterization of CCL28,CXCL14, and CXCL17, three mucosal chemokines
-
批准号:8586295
-
项目类别:
-
资助金额:$37.61万
-
财政年份:2011
-
负责人:Albert Zlotnik
-
依托单位:
Characterization of CCL28,CXCL14, and CXCL17, three mucosal chemokines
-
批准号:8971946
-
项目类别:
-
资助金额:$37.41万
-
财政年份:2011
-
负责人:Albert Zlotnik
-
依托单位:
Characterization of IL36, a novel cytokine
-
批准号:8174696
-
项目类别:
-
资助金额:$22.24万
-
财政年份:2011
-
负责人:Albert Zlotnik
-
依托单位:
Characterization of CCL28,CXCL14, and CXCL17, three mucosal chemokines
-
批准号:8774573
-
项目类别:
-
资助金额:$37.54万
-
财政年份:2011
-
负责人:Albert Zlotnik
-
依托单位:
Functional Characterization of CXCL14, CXCL17, and CCL28; three mucosal chemokine
-
批准号:7707125
-
项目类别:
-
资助金额:$21.71万
-
财政年份:2009
-
负责人:Albert Zlotnik
-
依托单位:
海外基金